Astrazeneca (AZN)

 

Latest News

Trial shows AZ's Tagrisso superiority over chemotherapy

AstraZeneca today presented data which show that Tagrisso (osimertinib) could replace chemotherapy as the standard of c...

Tagrisso data shows superiority over chemotherapy

RNS Number: 0793R AstraZeneca PLC 06 December 2016 06 December 2016 09:30 TAGRISSO DEMONSTRATES SUPERIORITY OVER CHEMOTHERAPY IN EGFR T790M MUTATION-POSITIVE NON-SMALL CELL LUNG CANCER First randomised Phase III trial (AURA3) of Tagrisso against chemotherapy Tagrisso reduced risk of disease progression by 70...

FTSE mixed with blue chips up on miners

London stocks were mixed in early deals as the market continued to digest news of Italy's Prime Minister, Matteo Renzi, qu...

AZ completes agreement on Rhinocort Aqua rights

AstraZeneca has completed the agreement with Cilag GmbH International, an affiliate of Johnson & Johnson, for the dive...

All News

DateHeadlineSource
06-12-16Trial shows AZ's Tagrisso superiority over chemotherapy StockMarketWire
06-12-16Tagrisso data shows superiority over chemotherapyRNS
05-12-16FTSE mixed with blue chips up on miners StockMarketWire
05-12-16AZ completes agreement on Rhinocort Aqua rights StockMarketWire
05-12-16AZ completes agreement for Rhinocort Aqua rightsRNS
01-12-16Block listing Interim ReviewRNS
01-12-16Total Voting RightsRNS
30-11-16Floats, mergers and meltdowns: 21 years of the FTSE 100Interactive Investor
28-11-16Broker Forecast - JP Morgan Cazenove issues a broker note on AstraZeneca PLCStockMarketWire
25-11-16Is AstraZeneca plc or GlaxoSmithKline plc the best Black Friday buy?Motley Fool
22-11-16AZ head and neck cancer trials resume enrolmentStockMarketWire
22-11-16AZ head and neck cancer trials resume enrolmentRNS
17-11-16Here are Neil Woodford's latest tradesInteractive Investor
17-11-16Broker Forecast - Berenberg issues a broker note on AstraZeneca PLCStockMarketWire
17-11-16AZ completes out-licensing deal with AllerganStockMarketWire
15-11-16Broker Forecast - Deutsche Bank issues a broker note on AstraZeneca PLCStockMarketWire
14-11-16Shares rally as Trump goes softInteractive Investor
14-11-16Broker Forecast - Exane BNP Paribas issues a broker note on AstraZeneca PLCStockMarketWire
11-11-16Broker Forecast - Jefferies International issues a broker note on AstraZeneca PLCStockMarketWire
10-11-16AstraZeneca maintains guidance StockMarketWire
10-11-16Year-To-Date and Q3 2016 ResultsRNS
09-11-16It's Trump! So how come FTSE 100 hasn't crashed? Interactive Investor
09-11-16Directorate ChangeRNS
01-11-16Dealing by Person Closely AssociatedRNS
01-11-16Total Voting RightsRNS
01-11-1613 dividend stocks among best in EuropeInteractive Investor
31-10-16AZ completes US Aralez deal for Toprol-XLStockMarketWire
31-10-16AZ completes US Aralez agreement for Toprol-XLRNS
27-10-16AstraZeneca Head and Neck Cancer TrialsRNS
26-10-16AZN confirms positive trial results StockMarketWire
26-10-16Positive results in AstraZeneca Lynparza trialRNS
21-10-16Nick Train reveals what will drive long-term FTSE returnsInteractive Investor
18-10-16FDA accepts AZ unit's new drug application resubmissionStockMarketWire
18-10-16FDA accepts for review ZS-9 NDA for hyperkalaemiaRNS
13-10-16Broker Forecast - Jefferies International issues a broker note on AstraZeneca PLCStockMarketWire
07-10-16FTSE ahead on miners, aided by pharmas, utilitiesStockMarketWire
07-10-16AZ divests rights to Rhinocort Aqua outside USStockMarketWire
07-10-16AZ DIVESTS RIGHTS TO RHINOCORT AQUA OUTSIDE USRNS
04-10-16FTSE closes close to its record high StockMarketWire
04-10-16Broker Forecast - Bryan Garnier issues a broker note on AstraZeneca PLCStockMarketWire

RSS feeds

  • Editorial news feed for LSE:AZN Editorial
  • Regulatory news feed for LSE:AZN Regulatory